SLNO   $33.48  9.99% Market Closed After Close 34.552 3.20%

Soleno Therapeutics, Inc.
Total Cash 266.12M
totalCashPerShare 6.846
EBITDA -66.53M
Total Debt 296.00K
quickRatio 29.084
currentRatio 29.235
Total Revenue
debtToEquity 0.105
Revenue/Share
ROA -0.25552
ROE -0.44619998
grossProfits
freeCashflow -23.13M
operatingCashflow -42.83M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 1.93B
forwardPE -27.33654
floatShares 21.20M
sharesOutstanding 38.87M
sharesShort 5.71M
sharesShortPriorMonth 4.66M
dateShortInterest
sharesPercentSharesOut 0.15%
heldPercentInsiders 0.03%
heldPercentInstitutions 1.03%
Short Ratio help_outline 7.51%
shortPercentOfFloat 0.24%
impliedSharesOutstanding
bookValue 7.314
Price To Book help_outline 7.77
earningsQuarterlyGrowth
netIncomeToCommon -65.41M
trailingEps -1.83%
forwardEps -2.08%
enterpriseToEbitda -28.95
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.63 3Q 2024
institutionsCount 171
lastUpdated Nov. 7, 2024, 2:39 a.m.